Skip to content
zameds

Methylprednisolone aceponate

Sold as Advantan scalp, Advantan milk, Macepatan, Adexityl, Vantiglen, Metiderm, Vantaderm, Macepatan fatty, Advantan, Advantan fatty

S4Read from the PI-PIL document and verified
Loading the molecular structure
C27H36O7472.60 g/mol

[(6S,8S,9S,10R,11S,13S,14S,17R)-17-(2-Acetyloxyacetyl)-11-hydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl] propanoate

Drag to rotate. Structure from PubChem CID 63019.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
4
Registrations
16
Schedule source
SAHPRA documentation

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Adcock ingram limitedCertificate held by Bayer (Pty) Ltd1 of 5 cancelledAdvantan scalp, Advantan milk, Advantan, Advantan fattysolution, 1 mg / g, 1mg, ointment320361, 320362, X0384, X0385, X0386S4PIPIL
Pharmacare limited û woodmeadCertificate held by Pharmacare limited, Pharmacare LtdMacepatan, Macepatan fattyointment, 1 mg, 10 mg/200 mg/350 mg510330, 560423, 590670S4PIPIL
Glenmark Pharmaceuticals South Africa (Pty) LtdAdexityl, Vantiglenemulsion, cream540493, 540494, 540495, 540496.495Not determinedNone
Abex Pharmaceutica (Pty) LtdMetiderm, Vantaderm1 mg, ointment580151, 580152.151, 590160, 590161.160S4PIPIL

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Advantan scalp solution

EACH 1,0 ml SOLUTION CONTAINS: METHYLPREDNISOLONE ACEPONATE 1,0 mg

Solution32036132/13.4.1/0361CancelledNot determinedNone
Advantan milk

EACH 100,0 g EMULSION CONTAINS METHYLPREDNISOLONE ACEPONATE 100,0 mg

1 mg / gEmulsion.32036232/13.4.1/0362Approved 8 May 2023RegisteredNot determinedPIPIL
Macepatan ointment

EACH 1,0 g OF OINTMENT CONTAINS METHYLPREDNISOLONE ACEPONATE 1,0 mg

Ointment51033051/13.4.1/0330RegisteredNot determinedNone
Adexityl emulsion

EACH 1,0 g EMULSION CONTAINS METHYLPREDNISOLONE ACEPONATE 1,0 mg

Emulsion54049354/13.4.1/0493RegisteredNot determinedNone
Vantiglen emulsion

EACH 1,0 g EMULSION CONTAINS METHYLPREDNISOLONE ACEPONATE 1,0 mg

Emulsion54049454/13.4.1/0494.493RegisteredNot determinedNone
Adexityl cream

EACH 1,0 g CREAM CONTAINS METHYLPREDNISOLONE ACEPONATE 1,0 mg

Cream54049554/13.4.1/0495RegisteredNot determinedNone
Vantiglen cream

EACH 1,0 g CREAM CONTAINS METHYLPREDNISOLONE ACEPONATE 1,0 mg

Cream540496.49554/13.4.1/0496.495RegisteredNot determinedNone
Macepatan cream

EACH 1,0 g CREAM CONTAINS METHYLPREDNISOLONE ACEPONATE 0,1% m/m

10 mg/200 mg/350 mgCream.56042356/13.4.1/0423Approved 23 July 2024RegisteredS4PIPIL
Metiderm cream

EACH 1,0 g CREAM CONTAINS: METHYLPREDNISOLONE ACEPONATE 1,0 mg

1 mgCream58015158/13.4.1/0151Approved 25 November 2025RegisteredS4PIPIL
Vantaderm cream

EACH 1,0 g CREAM CONTAINS: METHYLPREDNISOLONE ACEPONATE 1,0 mg

1 mgCream580152.15158/13.4.1/0152.151Approved 25 November 2025RegisteredS4PIPIL
Metiderm ointment

EACH 1,0 g OF OINTMENT CONTAINS: METHYLPREDNISOLONE ACEPONATE 1,0 mg

Ointment59016059/13.4.1/0160RegisteredNot determinedNone
Vantaderm ointment

EACH 1,0 g OF OINTMENT CONTAINS: METHYLPREDNISOLONE ACEPONATE 1,0 mg

Ointment590161.16059/13.4.1/0161.160RegisteredNot determinedNone
Macepatan fatty ointment

EACH 1,0 g OF OINTMENT CONTAINS: METHYLPREDNISOLONE ACEPONATE 1,0 mg

1 mgFatty ointment59067059/13.4.1/0670Approved 30 June 2026RegisteredS4PIPIL
Advantan cream

EACH 1 g CREAM CONTAINS METHYLPREDNISOLONE ACEPONATE 1 mg

1mgCream. Ointment. Fatty ointmentX0384X/13.4.1/384Approved 8 May 1992RegisteredS4PI
Advantan ointment

EACH 1 g OINTMENT CONTAINS METHYLPREDNISOLONE ACEPONATE 1 mg

OintmentX0385X/13.4.1/385RegisteredNot determinedNone
Advantan fatty ointment

EACH 1 g OINTMENT CONTAINS METHYLPREDNISOLONE ACEPONATE 1 mg

OintmentX0386X/13.4.1/386RegisteredNot determinedNone

Regulatory status

Where S4 sits on the scale

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, read from the product's PI-PIL leaflet.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading...
Loading PubMed articles